22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › UNITED THERAPEUTICS CORP. › 2024-2025

UNITED THERAPEUTICS CORP. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and UNITED THERAPEUTICS CORP.’s Form 8-K, filed June 27, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 15Ballot items
  • 639Asset managers, any item
  • 10,859Fund votes
  • June 26, 2025Meeting date

Results at a glance

Meeting of June 26, 2025: 15 items on UNITED THERAPEUTICS CORP.’s Form 8-K, filed June 27, 2025: 15 passed (calculated).

Dissent

Notable dissent: 2 directors (13.2%, 11.4% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore UNITED THERAPEUTICS CORP. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by UNITED THERAPEUTICS CORP.

These tallies are UNITED THERAPEUTICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 27, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

UNITED THERAPEUTICS CORP. — official shareholder meeting results, meeting held June 26, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Christopher Causey 34,893,6875,296,66116,365 --1,296,357 87%Passed (calculated)—
Elect Director: Raymond Dwek 36,254,5793,935,77416,360 --1,296,357 90%Passed (calculated)—
Elect Director: Richard Giltner 37,971,7062,218,88416,123 --1,296,357 94%Passed (calculated)—
Elect Director: Ray Kurzweil 38,353,5261,836,84516,342 --1,296,357 95%Passed (calculated)—
Elect Director: Jan Malcolm 39,688,758500,26417,691 --1,296,357 99%Passed (calculated)—
Elect Director: Linda Maxwell 39,715,114474,45017,149 --1,296,357 99%Passed (calculated)—
Elect Director: Nilda Mesa 39,346,176833,06727,470 --1,296,357 98%Passed (calculated)—
Elect Director: Judy Olian 39,832,045357,02317,645 --1,296,357 99.1%Passed (calculated)—
Elect Director: Christopher Patusky 35,613,2124,577,17116,330 --1,296,357 89%Passed (calculated)—
Elect Director: Martine Rothblatt 37,651,6712,539,84015,202 --1,296,357 94%Passed (calculated)—
Elect Director: Louis Sullivan 36,302,1693,875,03029,514 --1,296,357 90%Passed (calculated)—
Elect Director: Tommy Thompson 38,598,1381,590,04018,535 --1,296,357 96%Passed (calculated)—
2. Advisory resolution to approve executive compensation 38,413,7761,763,71229,225 --1,296,357 96%Passed (calculated)—
3. Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan 36,901,4843,277,69527,534 --1,296,357 92%Passed (calculated)—
4. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025 39,345,9172,142,85214,301 ---- 95%Passed (calculated)—

Source: UNITED THERAPEUTICS CORP., Form 8-K, filed with the SEC on June 27, 2025 — read the filing on EDGAR.

How asset managers voted at the UNITED THERAPEUTICS CORP. 2024-2025 meeting

639 asset managers disclosed a vote on at least one UNITED THERAPEUTICS CORP. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Christopher Causey

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 34,893,687AGAINST: 5,296,661

Prior year: 86.7% for (June 26, 2024 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Christopher Causey

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Causey”): 34,893,687 for, 5,296,661 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 15,721,586 for, 1,290,959 against, 12,176 abstained, 22 not voted.

FOR
FOR: 15,721,586AGAINST: 1,290,959ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Christopher Causey” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4571 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street2,671720,613 00Against
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA0232,026 00Against
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National11,86484,366 00Mixed
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
AllianceBernstein71,5170 00For
Brighthouse67,157482 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Elect Director: Christopher Patusky

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 35,613,212AGAINST: 4,577,171

Prior year: 89.4% for (June 26, 2024 meeting) ▼ 0.8 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Christopher Patusky

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Patusky”): 35,613,212 for, 4,577,171 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 16,239,791 for, 776,999 against, 12,176 abstained, 22 not voted.

FOR
FOR: 16,239,791AGAINST: 776,999ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Christopher Patusky” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4571 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street2,671720,613 00Against
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Elect Director: Jan Malcolm

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 39,688,758AGAINST: 500,264

Prior year: 99.6% for (June 26, 2024 meeting) ▼ 0.8 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Jan Malcolm

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Jan Malcolm”): 39,688,758 for, 500,264 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 16,982,074 for, 34,716 against, 12,176 abstained, 22 not voted.

FOR
FOR: 16,982,074AGAINST: 34,716ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Jan Malcolm” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4580 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street723,2840 00For
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Elect Director: Judy Olian

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 39,832,045AGAINST: 357,023

Prior year: 99.2% for (June 26, 2024 meeting) unchanged

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Judy Olian

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Judy Olian”): 39,832,045 for, 357,023 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 17,015,067 for, 1,723 against, 12,176 abstained, 22 not voted.

FOR
FOR: 17,015,067AGAINST: 1,723ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Judy Olian” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4580 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street723,2840 00For
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Elect Director: Linda Maxwell

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 39,715,114AGAINST: 474,450

Prior year: 99.0% for (June 26, 2024 meeting) ▼ 0.2 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Linda Maxwell

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Linda Maxwell”): 39,715,114 for, 474,450 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 17,016,789 for, 0 against, 12,176 abstained, 22 not voted.

FOR
FOR: 17,016,789AGAINST: 0ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Linda Maxwell” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4580 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street723,2840 00For
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Elect Director: Louis Sullivan

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%
FOR: 36,302,169AGAINST: 3,875,030

Prior year: 91.4% for (June 26, 2024 meeting) ▼ 1.0 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Louis Sullivan

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Louis Sullivan”): 36,302,169 for, 3,875,030 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 16,241,263 for, 775,527 against, 12,176 abstained, 22 not voted.

FOR
FOR: 16,241,263AGAINST: 775,527ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Louis Sullivan” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4571 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street2,671720,613 00Against
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Elect Director: Martine Rothblatt

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 37,651,671AGAINST: 2,539,840

Prior year: 93.5% for (June 26, 2024 meeting) ▲ 0.2 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Martine Rothblatt

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Martine Rothblatt”): 37,651,671 for, 2,539,840 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 16,947,609 for, 69,181 against, 12,176 abstained, 22 not voted.

FOR
FOR: 16,947,609AGAINST: 69,181ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Martine Rothblatt” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4580 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street723,24044 00For
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock147,57636,433 00Mixed
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Elect Director: Nilda Mesa

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 39,346,176AGAINST: 833,067

Prior year: 97.4% for (June 26, 2024 meeting) ▲ 0.5 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Nilda Mesa

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Nilda Mesa”): 39,346,176 for, 833,067 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 17,011,275 for, 5,515 against, 12,176 abstained, 22 not voted.

FOR
FOR: 17,011,275AGAINST: 5,515ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Nilda Mesa” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4580 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street723,2840 00For
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Elect Director: Ray Kurzweil

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 38,353,526AGAINST: 1,836,845

Prior year: 92.6% for (June 26, 2024 meeting) ▲ 2.8 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Ray Kurzweil

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Ray Kurzweil”): 38,353,526 for, 1,836,845 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 16,950,303 for, 66,487 against, 12,176 abstained, 22 not voted.

FOR
FOR: 16,950,303AGAINST: 66,487ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Ray Kurzweil” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4580 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street723,24044 00For
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Elect Director: Raymond Dwek

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%
FOR: 36,254,579AGAINST: 3,935,774

Prior year: 91.7% for (June 26, 2024 meeting) ▼ 1.5 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Raymond Dwek

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Raymond Dwek”): 36,254,579 for, 3,935,774 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 16,198,893 for, 817,897 against, 12,176 abstained, 22 not voted.

FOR
FOR: 16,198,893AGAINST: 817,897ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Raymond Dwek” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4571 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street2,671720,613 00Against
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Elect Director: Richard Giltner

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 37,971,706AGAINST: 2,218,884

Prior year: 95.4% for (June 26, 2024 meeting) ▼ 0.9 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Richard Giltner

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Richard Giltner”): 37,971,706 for, 2,218,884 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 16,975,950 for, 40,840 against, 12,176 abstained, 22 not voted.

FOR
FOR: 16,975,950AGAINST: 40,840ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Richard Giltner” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4580 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street723,24044 00For
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Elect Director: Tommy Thompson

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 38,598,138AGAINST: 1,590,040

Prior year: 96.3% for (June 26, 2024 meeting) ▼ 0.3 pts

Details: description as filed, official tally, votes by 153 asset managers

Description as filed by funds: Election of Directors: Tommy Thompson

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Tommy Thompson”): 38,598,138 for, 1,590,040 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 16,979,741 for, 37,049 against, 12,176 abstained, 22 not voted.

FOR
FOR: 16,979,741AGAINST: 37,049ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “Election of Directors: Tommy Thompson” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4580 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street723,24044 00For
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).

Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock…

Calculated outcomeFund totals may overlapCOMPENSATIONPassed (calculated)

Combines 6 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 36,901,484AGAINST: 3,277,695

Prior year: 87.6% for (June 26, 2024 meeting) ▲ 4.2 pts

Details: description as filed, official tally, votes by 160 asset managers

Description as filed by funds: APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN.

UNITED THERAPEUTICS CORP.’s own tally for this item (“3. Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan”): 36,901,484 for, 3,277,695 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 148 asset managers voting on “APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STO” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,395,4580 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street723,24044 00For
Pacer Funds Trust0500,680 00Against
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National11,86484,366 00Mixed
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Fund voting reports, all 148 managers: 16,119,905 for, 811,060 against, 12,176 abstained, 22 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 11 asset managers voting on “APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STO” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Eversept Partners, LP130,3660 00For
TOCQUEVILLE ASSET MANAGEMENT L.P.033,900 00Against
Erste Asset Management GmbH25,3410 00For
Cardano Risk Management B.V.18,7940 00For
Decatur Capital Management, Inc.7,7090 00For
OSSIAM1,4560 00For
EAGLE GLOBAL ADVISORS LLC5000 00For
UNITED CAPITAL FINANCIAL ADVISORS, LLC0444 00Against
LEAVELL INVESTMENT MANAGEMENT, INC.00 00--
Hendershot Investments Inc.0200 00Against
BRANDYWINE OAK PRIVATE WEALTH LLC810 00For

Institutional-manager reports, all 11 managers: 184,247 for, 34,544 against, 411 unknown.

Advisory resolution to approve executive compensation

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 12 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 38,413,776AGAINST: 1,763,712

Prior year: 94.8% for (June 26, 2024 meeting) ▲ 0.9 pts

Details: description as filed, official tally, votes by 636 asset managers

Description as filed by funds: Advisory resolution to approve executive compensation.

UNITED THERAPEUTICS CORP.’s own tally for this item (“2. An advisory resolution to approve executive compensation”): 38,413,776 for, 1,763,712 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of UNITED THERAPEUTICS CORP.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Compensation” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 148 asset managers voting on “Advisory resolution to approve executive compensation.” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,394,860598 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street723,2840 00For
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI156,5801,838 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price86,1467,400 00Mixed
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,8840 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Fund voting reports, all 148 managers: 16,846,766 for, 94,290 against, 12,176 abstained, 22 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 518 asset managers voting on “Advisory resolution to approve executive compensation.” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,009,396293 00For
State Street1,948,6160 00For
Wellington1,815,4960 00For
Renaissance1,644,9570 00For
Avoro Capital Advisors LLC1,249,3290 00For
GEODE CAPITAL MANAGEMENT, LLC1,217,4950 00For
Fidelity1,208,4210 00For
AQR562,9040 00For
LSV ASSET MANAGEMENT523,1850 00For
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC518,2360 00For
FULLER & THALER ASSET MANAGEMENT, INC.474,8810 00For
FRONTIER CAPITAL MANAGEMENT CO LLC209,748209,748 00Mixed
Invesco403,0030 00For
DEERFIELD MANAGEMENT COMPANY, L.P.386,7440 00For
Charles Schwab354,5900 00For
Amundi0345,482 00Against
AllianceBernstein343,8600 00For
Northern Trust335,0440 00For
Swedbank Robur Fonder AB321,4050 00For
MELLON INVESTMENTS Corp310,8490 00For
Epoch Investment Partners, Inc.288,4840 00For
AustralianSuper Pty Ltd284,6160 00For
Nuveen274,0920 00For
ASSETMARK, INC270,061952 00For
LORD, ABBETT & CO. LLC261,9910 00For

Institutional-manager reports, all 518 managers: 25,161,587 for, 1,376,715 against, 6,057 abstained, 1,620 not voted, 411 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 39,345,917AGAINST: 2,142,852

Prior year: 96.4% for (June 26, 2024 meeting) ▼ 1.6 pts

Details: description as filed, official tally, votes by 152 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2025.

UNITED THERAPEUTICS CORP.’s own tally for this item (“4. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025”): 39,345,917 for, 2,142,852 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 152 asset managers below reported 16,971,460 for, 26,536 against, 12,176 abstained, 22 not voted.

FOR
FOR: 16,971,460AGAINST: 26,536ABSTAIN: 12,176NOT VOTED: 22
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at UNITED THERAPEUTICS CORP., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,394,860598 00For
BlackRock2,949,1350 00For
Fidelity2,104,5990 00For
State Street723,24044 00For
Pacer Funds Trust500,6800 00For
Capitol Series Trust455,4570 00For
Charles Schwab349,3690 00For
Invesco331,9760 00For
First Trust306,6130 00For
Victory Capital303,7300 00For
TIAA232,0260 00For
Lord Abbett220,5140 00For
Thrivent203,8330 00For
John Hancock184,0090 00For
AQR169,9110 00For
SEI158,4180 00For
JPMorgan112,3350 00For
Jackson National96,2300 00For
Dimensional95,6320 00For
T. Rowe Price93,5460 00For
Equitable83,1500 00For
AIG/SunAmerica73,6550 00For
Brighthouse71,402482 00For
AllianceBernstein71,5170 00For
Bridge Builder Trust62,8780 00For

Showing the 25 largest of 152 asset managers. All 152 are in the interactive database (link above).

Largest UNITED THERAPEUTICS CORP. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 45,074,551 shares outstanding at the time of that meeting.

Fund voting reports: top UNITED THERAPEUTICS CORP. shareholders by shares voted on “Advisory resolution to approve executive compensation.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 11.97%
2BlackRock 6.54%
3Fidelity 4.67%
4State Street 1.60%
5Pacer Funds Trust 1.11%
6Capitol Series Trust 1.01%
7Charles Schwab 0.78%
8Invesco 0.74%
9First Trust 0.68%
10Victory Capital 0.67%
Institutional-manager reports: top UNITED THERAPEUTICS CORP. shareholders by shares voted on “Advisory resolution to approve executive compensation.”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 4.46%
2State Street 4.32%
3Wellington 4.03%
4Renaissance 3.65%
5Avoro Capital Advisors LLC 2.77%
6GEODE CAPITAL MANAGEMENT, LLC 2.70%
7Fidelity 2.68%
8AQR 1.25%
9LSV ASSET MANAGEMENT 1.16%
10CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 1.15%

Reported UNITED THERAPEUTICS CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

UNITED THERAPEUTICS CORP. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock5,446,092 12.08%Form 13F, quarter ended March 31, 2025
Vanguard Group4,457,135 9.89%Form 13F, quarter ended March 31, 2025
Martine Rothblatt3,193,762 7.09%Proxy statement (DEF 14A), proxy filed April 29, 2025
Avoro Capital Advisors LLC2,858,888 6.34%Proxy statement (DEF 14A), proxy filed April 29, 2025
FMR LLC2,321,039 5.15%Proxy statement (DEF 14A), proxy filed April 29, 2025
State Street2,230,708 4.95%Form 13F, quarter ended March 31, 2025
Renaissance Technologies2,106,992 4.67%Form 13F, quarter ended March 31, 2025
Wellington Management2,026,416 4.50%Form 13F, quarter ended March 31, 2025
FMR (Fidelity)1,144,603 2.54%Form 13F, quarter ended March 31, 2025
Dimensional Fund Advisors624,711 1.39%Form 13F, quarter ended March 31, 2025

Percentages above are of 45,074,551 shares outstanding, as reported by UNITED THERAPEUTICS CORP. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At UNITED THERAPEUTICS CORP.'s shareholder meeting held June 26, 2025, in the 2024-2025 proxy season, 639 asset managers reported votes on at least one of its 15 ballot items in their SEC Form N-PX filings, covering 10,859 separate fund positions. On the most widely held item on that ballot — Advisory resolution to approve executive compensation. — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: UNITED THERAPEUTICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 27, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from UNITED THERAPEUTICS CORP.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

UNITED THERAPEUTICS CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “UNITED THERAPEUTICS (UTHR) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/united-therapeutics-corp/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.